BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25876778)

  • 1. [Pathogenesis of chronic lymphocytic leukemia].
    Fukuda T
    Rinsho Ketsueki; 2015 Mar; 56(3):261-8. PubMed ID: 25876778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of chronic lymphocytic leukemia.
    Zhang S; Kipps TJ
    Annu Rev Pathol; 2014; 9():103-18. PubMed ID: 23987584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SnapShot: Chronic Lymphocytic Leukemia.
    Ten Hacken E; Guièze R; Wu CJ
    Cancer Cell; 2017 Nov; 32(5):716-716.e1. PubMed ID: 29136511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions.
    Mansouri L; Papakonstantinou N; Ntoufa S; Stamatopoulos K; Rosenquist R
    Semin Cancer Biol; 2016 Aug; 39():40-8. PubMed ID: 27491692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic lymphocytic leukemia: biology, disease progression, and current treatment strategies].
    Yano T
    Rinsho Ketsueki; 2017; 58(10):1960-1972. PubMed ID: 28978838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia.
    Jethwa A; Hüllein J; Stolz T; Blume C; Sellner L; Jauch A; Sill M; Kater AP; te Raa GD; Geisler C; van Oers M; Dietrich S; Dreger P; Ho AD; Paruzynski A; Schmidt M; von Kalle C; Glimm H; Zenz T
    Br J Haematol; 2013 Nov; 163(4):496-500. PubMed ID: 24032483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications.
    Rombout A; Verhasselt B; Philippé J
    Eur J Haematol; 2016 Nov; 97(5):409-415. PubMed ID: 27504855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia.
    Sutton LA; Rosenquist R
    Semin Cancer Biol; 2015 Oct; 34():22-35. PubMed ID: 25963298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling pathways activated by the B-cell receptor in chronic lymphocytic leukemia.
    Scupoli MT; Pizzolo G
    Expert Rev Hematol; 2012 Jun; 5(3):341-8. PubMed ID: 22780213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LYN Kinase in the Tumor Microenvironment Is Essential for the Progression of Chronic Lymphocytic Leukemia.
    Nguyen PH; Fedorchenko O; Rosen N; Koch M; Barthel R; Winarski T; Florin A; Wunderlich FT; Reinart N; Hallek M
    Cancer Cell; 2016 Oct; 30(4):610-622. PubMed ID: 27728807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis.
    Vosoughi T; Bagheri M; Hosseinzadeh M; Ehsanpour A; Davari N; Saki N
    J Cell Physiol; 2019 Nov; 234(11):19420-19439. PubMed ID: 31049958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal diversity analysis using SNP microarray: a new prognostic tool for chronic lymphocytic leukemia.
    Zhang L; Znoyko I; Costa LJ; Conlin LK; Daber RD; Self SE; Wolff DJ
    Cancer Genet; 2011 Dec; 204(12):654-65. PubMed ID: 22285017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chronic lymphocytic leukemia microenvironment: Beyond the B-cell receptor.
    Choi MY; Kashyap MK; Kumar D
    Best Pract Res Clin Haematol; 2016 Mar; 29(1):40-53. PubMed ID: 27742071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?
    Caligaris-Cappio F; Ghia P
    J Clin Oncol; 2008 Sep; 26(27):4497-503. PubMed ID: 18662968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of the expression of CD32 and CD180 receptors on CLL cells and MEC1 cell line.
    Tsertsvadze T; Mitskevich N; Ghirdaladze D; Porakishvili N
    Georgian Med News; 2015 Mar; (240):56-9. PubMed ID: 25879560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel insights into the biology of CLL.
    Lanasa MC
    Hematology Am Soc Hematol Educ Program; 2010; 2010():70-6. PubMed ID: 21239773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia.
    Bresin A; D'Abundo L; Narducci MG; Fiorenza MT; Croce CM; Negrini M; Russo G
    Cell Death Dis; 2016 Jan; 7(1):e2071. PubMed ID: 26821067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microenvironmental interactions in chronic lymphocytic leukemia: hints for pathogenesis and identification of targets for rational therapy.
    Dal Bo M; Bomben R; Zucchetto A; Del Poeta G; Gaidano G; Deaglio S; Efremov DG; Gattei V
    Curr Pharm Des; 2012; 18(23):3323-34. PubMed ID: 22591383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microenvironmental interactions in chronic lymphocytic leukemia: the master role of CD49d.
    Dal Bo M; Tissino E; Benedetti D; Caldana C; Bomben R; Del Poeta G; Gaidano G; Rossi FM; Zucchetto A; Gattei V
    Semin Hematol; 2014 Jul; 51(3):168-76. PubMed ID: 25048781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of signaling pathways and miRNAs in chronic lymphocytic leukemia.
    Li PP; Wang X
    Chin Med J (Engl); 2013 Nov; 126(21):4175-82. PubMed ID: 24229693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.